Cargando…
Survival Analysis Based on Clinicopathological Data from a Single Institution: Chemotherapy Intensity Would Be Enhanced in Patients with Positive Hormone Receptors and Positive HER2 in China Who Cannot Afford the Target Therapy
Background. Immunohistochemical markers were often used to classify breast cancer into subtypes. The aim of this study was to estimate death and tumor progression for patients with the major subtypes of breast cancer as classified using immunohistochemical assay and to investigate the patterns of be...
Autores principales: | Li, Jianyi, Jia, Shi, Zhang, Wenhai, Zhang, Yang, Fei, Xiang, Tian, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747482/ https://www.ncbi.nlm.nih.gov/pubmed/23984097 http://dx.doi.org/10.1155/2013/606398 |
Ejemplares similares
-
Organizations Cannot Afford to Stay Silent on Racial Injustice
por: Ruggs, Enrica, et al.
Publicado: (2020) -
Macular Hole Surgery in a Patient Who Cannot Maintain Facedown Positioning
por: Michalewska, Zofia, et al.
Publicado: (2013) -
Would 1.0 cm be a more suitable cutoff to subdivide pT1 tumors in hormone receptor‐negative and HER2‐positive breast cancer?
por: Wang, Changjun, et al.
Publicado: (2018) -
Biodiversity conservation cannot afford COVID-19 communication bungles
por: Gregg, Emily A., et al.
Publicado: (2021) -
Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast
por: Jang, Yunjeong, et al.
Publicado: (2020)